Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex

Neurobiology of Disease

Volumn 43, Issue 2, 2011, Pages 379-387

  Walker, Adam G ^a   Ummel, Jason R ^a   Rebec, George V ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Electrophysiology; Fear extinction; Huntington's disease; Prefrontal cortex; R6 2

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN DISEASE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; FACIAL EXPRESSION; FEAR; FREEZING; GENOTYPE; HUNTINGTON CHOREA; MALE; MEMORY; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE; TRAINING;

ANIMALS; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PREFRONTAL CORTEX;

EID: 79958242681     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.04.009     Document Type: Article

References (57)

1. Abeles M. Quantification, smoothing, and confidence limits for single-units' histograms. J. Neurosci. Methods 1982, 5:317-325.
2. Balcombe J.P. Laboratory environments and rodents' behavioural needs: a review. Lab. Anim. 2006, 40:217-235.
3. Bolivar V.J., Manley K., Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav. Neurosci. 2003, 117:1233-1242.
4. Bouton M.E.M. Conditioned fear assessed by freezing and by the suppression of three different baselines. Anim. Learn. Behav. 1980, 8:429-434.
5. Methods of behavior analysis in neuroscience 2009, CRC Press, Boca Raton. J.J. Buccafusco (Ed.).
6. Burgos-Robles A., Vidal-Gonzalez I., Quirk G.J. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J. Neurosci. 2009, 29:8474-8482.
7. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999, 19:3248-3257.
8. Cepeda C., Cummings D.M., Andre V.M., Holley S.M., Levine M.S. Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms. ASN Neuro 2010, 2:e00033.
9. Ciamei A., Morton A.J. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease. Neurobiol. Learn. Mem. 2009, 92:417-428.
10. Corcoran K.A., Quirk G.J. Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. J. Neurosci. 2007, 27:840-844.
11. Crook Z.R., Housman D. Huntington's disease: can mice lead the way to treatment?. Neuron 2011, 69:423-435.
12. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997, 90:537-548.
13. File S.E., Mahal A., Mangiarini L., Bates G.P. Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res. 1998, 805:234-240.
14. Heng M.Y., Detloff P.J., Albin R.L. Rodent genetic models of Huntington disease. Neurobiol. Dis. 2008, 32:1-9.
15. Hickey M.A., Gallant K., Gross G.G., Levine M.S., Chesselet M.F. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol. Dis. 2005, 20:1-11.
16. Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157:280-295.
17. Hurlbert M.S., Zhou W., Wasmeier C., Kaddis F.G., Hutton J.C., Freed C.R. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 1999, 48:649-651.
18. Klapstein G.J., Fisher R.S., Zanjani H., Cepeda C., Jokel E.S., Chesselet M.F., et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 2001, 86:2667-2677.
19. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119:1633-1645.
20. Lawrence A.D., Sahakian B.J., Robbins T.W. Cognitive functions and corticostriatal circuits: insights from Huntington's disease. Trends Cogn. Sci. 1998, 2:379-388.
21. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
22. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 1999, 19:10428-10437.
23. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
24. Meade C.A., Deng Y.P., Fusco F.R., Del Mar N., Hersch S., Goldowitz D., et al. Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol. 2002, 449:241-269.
25. Menalled L., El-Khodor B.F., Patry M., Suarez-Farinas M., Orenstein S.J., Zahasky B., et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol. Dis. 2009, 35:319-336.
26. Milad M.R., Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002, 420:70-74.
27. Miller B.R., Walker A.G., Shah A.S., Barton S.J., Rebec G.V. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J. Neurophysiol. 2008, 100:2205-2216.
28. Montoya A., Price B.H., Menear M., Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J. Psychiatry Neurosci. 2006, 31:21-29.
29. Murphy K.P., Carter R.J., Lione L.A., Mangiarini L., Mahal A., Bates G.P., et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci. 2000, 20:5115-5123.
30. Naver B., Stub C., Moller M., Fenger K., Hansen A.K., Hasholt L., et al. Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience 2003, 122:1049-1057.
31. Nguyen H.P., Kobbe P., Rahne H., Worpel T., Jager B., Stephan M., et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum. Mol. Genet. 2006, 15:3177-3194.
32. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. Am. J. Neuroradiol. 2004, 25:1715-1721.
33. Pavlov I.P., Anrep G.V.e. Conditioned reflexes; an investigation of the physiological activity of the cerebral cortex 1927, Oxford Univ. Press, London.
34. Paxinos G., Franklin K. The Mouse Brain in Stereotaxic Coordinates, Deluxe Second Edition (with CD-ROM) 2001, Academic Press.
35. Pohar M., Blas M., Turk S. Comparison of logistic regression and linear discriminant analysis: a simulation study. Metodoloski Zvezki 2004, 1:143-161.
36. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33:56-72.
37. Quirk G.J., Garcia R., Gonzalez-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol. Psychiatry 2006, 60:337-343.
38. Rosenblatt A. Neuropsychiatry of Huntington's disease. Dialogues Clin. Neurosci. 2007, 9:191-197.
39. Rudy J.W., Huff N.C., Matus-Amat P. Understanding contextual fear conditioning: insights from a two-process model. Neurosci. Biobehav. Rev. 2004, 28:675-685.
40. Sawiak S.J., Wood N.I., Williams G.B., Morton A.J., Carpenter T.A. Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease. Neurobiol. Dis. 2009, 33:12-19.
41. Sawiak S.J., Wood N.I., Williams G.B., Morton A.J., Carpenter T.A. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol. Dis. 2009, 33:20-27.
42. Sierra-Mercado D., Corcoran K.A., Lebron-Milad K., Quirk G.J. Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. Eur. J. Neurosci. 2006, 24:1751-1758.
43. Sierra-Mercado D., Padilla-Coreano N., Quirk G.J. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2010, 36:529-538.
44. Sotres-Bayon F., Quirk G.J. Prefrontal control of fear: more than just extinction. Curr. Opin. Neurobiol. 2010, 20:231-235.
45. Statsoft inc Electronic Statistics Textbook 2010, Statsoft, Tulsa, OK.
46. Thiruvady D.R., Georgiou-Karistianis N., Egan G.F., Ray S., Sritharan A., Farrow M., et al. Functional connectivity of the prefrontal cortex in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:127-133.
47. Verny C., Allain P., Prudean A., Malinge M.C., Gohier B., Scherer C., et al. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur. J. Neurol. 2007, 14:1344-1350.
48. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn. Mem. 2006, 13:728-733.
49. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., et al. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 2003, 12:617-624.
50. Walker A.G., Miller B.R., Fritsch J.N., Barton S.J., Rebec G.V. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J. Neurosci. 2008, 28:8973-8982.
51. Wastell D.G. A simple randomisation procedure for validating discriminant analysis: a methodological note. Biol. Psychol. 1987, 24:123-127.
52. Wellman C.L., Izquierdo A.A., Garrett J.E., Martin K.P., Carroll J.J., Millstein R.R., et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 2007, 27:684-691.
53. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007, 130:2845-2857.
54. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp. Neurol. 2008, 213:137-144.
55. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum. Brain Mapp. 2009, 30:327-339.
56. Wood N.I., Carta V., Milde S., Skillings E.A., McAllister C.J., Ang Y.L., et al. Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. PLoS One 2010, 5:e9077.
57. Zakzanis K.K. The subcortical dementia of Huntington's disease. J. Clin. Exp. Neuropsychol. 1998, 20:565-578.